Further research is "urgently needed" to set up a successful screening process in order to prevent prostate cancer, a leading scientist has said.
Professor Fritz Schroder, who lead a major study into prostate screening, said more research was needed to reduce the number of men "screened, biopsied, and treated".
PSA screening delivers a substantial reduction in prostate cancer deaths, similar or greater than that reported in screening for breast cancer.
However, over-diagnosis occurs in roughly 40% of cases detected by screening resulting in a high risk of over-treatment and common side-effects such as incontinence and impotence.
The time for population-based screening has not arrived.
Further research is urgently needed on ways to reduce over-diagnosis preferably by avoiding unnecessary biopsy procedures, and reducing the very large number of men who must be screened, biopsied, and treated to help only a few patients.
More top news
The world's highest-paid actress earned less in the past 12 months than the 14 top-paid actors, it has been revealed.
The tour operator is relaunching its holidays from the UK to Tunisia for the first time since the Sousse beach attack that left 38 dead.
The former chancellor said a line connecting the east and west coasts must be planned for as the Government presses ahead with HS2.